CAI

Caris Life Sciences, Inc.

5 transactions on file, per SEC Form 4 filings.

Spetzler David Baxley

President · 2026-09-04

Option exercise

$610K

Spetzler David Baxley

President · 2026-09-04

Sold

$3.0M

Spetzler David Baxley

President · 2026-09-03

Option exercise

$2.4M

Spetzler David Baxley

President · 2026-09-03

Sold

$9.7M

Spetzler David Baxley

President · 2026-09-03

Sold

$2.1M

Each row links to the underlying SEC filing. Sells are shown for transparency, not as a signal — see the insider trading article for why.

Is CAI actually a buy?

Following an insider into a stock isn't a strategy on its own. Run your own margin-of-safety analysis, free.